Clinical Trial Update: Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy, tolerability and safety of etoricoxib (Arcoxia) in neuropathic pain, including postherpetic neuralgia and neuralgia; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuralgia
• Postherpetic Neuralgia

Drugs mentioned

• Etoricoxib (Arcoxia) (etoricoxib)

Snippet

Sponsor: Analgesic Solutions | Conditions: Postherpetic Neuralgia, Neuralgia | Phase 4 | Status: UNKNOWN